The FDA outlines its ibogaine trial vision, Compass Pathways reveals pricing and slow rollout plans, and early healthcare leaders weigh in—here’s what DMV readers need to know.

A latest federal court ruling risks unraveling commercial reliability in legal state cannabis markets. NORML urges that enforceable contracts are critical for consumer safety and industry trust.

Georgia’s medical cannabis program is expanding even as state regulators wait for input from the DEA. Here’s why it matters and what DMV readers should watch.

Federal cannabis rescheduling is expected to pull producers under the same GMP standards that govern other consumed products, with new equipment rules likely to follow.

Georgia, Vermont and California officials say DEA has offered little implementation guidance after marijuana moved to Schedule III for state medical programs, leaving labeling, taxes and inspections unclear.

Jamaica just rolled out two special permits to welcome traditional cultivators into the legal market. Here’s how that shift resonates across culture, equity, and the DMV.

State lawmakers in Tennessee held hours of hearings on a limited medical marijuana plan as the TBI opposed it and legislators challenged claims linking cannabis to violence.

Steven Froelich’s cocaine tale from Guatemala hits High Times. Here’s what it is (a personal narrative), what it isn’t (a policy change), and why DMV readers should care.

High Times reports 90% of Americans support legal cannabis, yet bipartisan lawmakers continue punitive approaches. Here’s how that disconnect shapes delivery rules, licensing talk, and compliance planning in the DMV.

A new Trump video praising CBD for older Americans sparked a market rally. Here’s what actually changed, what didn’t, and how DMV consumers and delivery operators should read the signal.

A Texas case profiled by High Times shows how extreme cannabis penalties still happen. Here’s what DMV readers should consider about risk, compliance and delivery rules.

A new Maryland law shields firefighters and rescue workers from discipline for off‑duty, lawful medical cannabis use—while keeping strict on‑duty impairment rules intact.

A new proposal dubbed Senate Bill 1 would route hemp-derived cannabinoids through pharmacies only, reshaping access, retail, and compliance—especially for delivery.

A plain‑English playbook for understanding marijuana delivery regulations, courier licensing and transport compliance—built for DC, Maryland and Virginia readers.

Weedmaps News flagged new coverage, but details are scarce. Here’s a DMV-first explainer to navigate cannabis delivery laws, licensing, and transport compliance without guessing.

A new survey indicates New York cannabis businesses already outpay other employers, even as many push back on a proposal to recommend a prevailing wage by late 2027.

State Democrats say adult-use marijuana in Pennsylvania won’t move without control of both legislative chambers. Here’s what’s known, what isn’t, and why DMV readers should care.

Shannon O’Brien files a fresh lawsuit alleging misconduct and public safety risks in a $1.6B market. Here’s why DMV delivery operators should care about the fallout.

Psychedelic Alpha flagged a busy “Psychedelics Week” in DC with multiple meetings. Here’s what that activity could signal for policy, access, and the DMV community.

MJBizDaily reports a Michigan retailer prevailed after blocking a nearby Flock camera. Here’s why surveillance around cannabis shops matters for delivery, compliance, and privacy.